Should Value Investors Buy VAREX IMAGING (VREX) Stock?

Zacks has identified VAREX IMAGING (VREX) as a compelling value stock, assigning it a Zacks Rank #2 (Buy) and an 'A' grade for Value. The company's current P/E ratio of 12.15 and P/S ratio of 0.58 are notably below industry averages of 21.66 and 1.69, respectively, suggesting it is undervalued. This, coupled with a strong earnings outlook, positions VREX as a potentially attractive investment for value-oriented portfolios.

Analysis

Varex Imaging (VREX) has been identified as a compelling value opportunity, meriting a Zacks Rank #2 (Buy) and a top-tier 'A' grade for Value. The company's valuation appears significantly discounted relative to its peers, with a current Price-to-Earnings (P/E) ratio of 12.15, substantially below the industry average of 21.66. This valuation is also positioned near the low end of its one-year forward P/E range of 11.66 to 26.48. The undervaluation thesis is further supported by the Price-to-Sales (P/S) ratio, which stands at 0.58 compared to an industry average of 1.69, indicating that the market is pricing its revenue stream at a steep discount. The combination of these favorable valuation metrics, alongside a reportedly strong earnings outlook, suggests a potential mispricing by the market.

Key Decisions for Investors

• Value-oriented investors should consider VREX as a potential long position, given the strong quantitative signals of undervaluation, including its P/E and P/S ratios being well below industry averages.
• Investors should monitor for a potential re-rating of the stock, where its valuation multiples begin to converge towards the industry benchmarks of a 21.66 P/E and 1.69 P/S.
• The positive thesis is contingent on the company's 'strong earnings outlook'; therefore, upcoming earnings releases should be scrutinized to confirm that fundamental performance supports the current value argument.